The Joint Corp. (JYNT) Bundle
Understanding The Joint Corp. (JYNT) Revenue Streams
Understanding The Joint Corp.’s Revenue Streams
As of September 30, 2024, the revenue streams of the company can be categorized into several primary sources:
- Revenues from Company-Owned or Managed Clinics: $17,544,658 for Q3 2024, down from $17,882,303 in Q3 2023, reflecting a decrease of 1.9%.
- Royalty Fees: $7,870,033 for Q3 2024, an increase from $7,143,791 in Q3 2023, marking a growth of 10.2%.
- Franchise Fees: $697,688 for Q3 2024, a decrease from $754,029 in Q3 2023, representing a drop of 7.5%.
- Advertising Fund Revenue: $2,247,663 for Q3 2024, up from $2,050,106 in Q3 2023, showing an increase of 9.6%.
- IT Related Income and Software Fees: $1,431,321 for Q3 2024, compared to $1,301,577 in Q3 2023, which is an increase of 10.0%.
- Other Revenues: $407,127 for Q3 2024, up from $342,143 in Q3 2023, a rise of 19.0%.
Overall, total revenues increased to $30,198,490 in Q3 2024 from $29,473,949 in Q3 2023, marking a growth of 2.5%.
| Revenue Source | Q3 2024 | Q3 2023 | Change ($) | Change (%) |
|---|---|---|---|---|
| Revenues from Company-Owned Clinics | $17,544,658 | $17,882,303 | $(337,645) | (1.9%) |
| Royalty Fees | $7,870,033 | $7,143,791 | $726,242 | 10.2% |
| Franchise Fees | $697,688 | $754,029 | $(56,341) | (7.5%) |
| Advertising Fund Revenue | $2,247,663 | $2,050,106 | $197,557 | 9.6% |
| IT Related Income and Software Fees | $1,431,321 | $1,301,577 | $129,744 | 10.0% |
| Other Revenues | $407,127 | $342,143 | $64,984 | 19.0% |
| Total Revenues | $30,198,490 | $29,473,949 | $724,541 | 2.5% |
For the nine months ended September 30, 2024, the revenue breakdown indicates:
- Revenues from Company-Owned or Managed Clinics: $52,730,898, a slight decrease from $52,813,098 in the same period of 2023, reflecting a 0.2% decline.
- Royalty Fees: $23,303,907, increasing from $21,181,973, indicating a 10.0% rise.
- Franchise Fees: $2,072,665, down from $2,179,822, showing a decrease of 4.9%.
- Advertising Fund Revenue: $6,654,974, up from $6,043,563, marking a growth of 10.1%.
- IT Related Income and Software Fees: $4,233,133, an increase from $3,746,394, representing a growth of 13.0%.
- Other Revenues: $1,185,640, which is an increase from $1,117,103, indicating a rise of 6.1%.
| Revenue Source | 9M 2024 | 9M 2023 | Change ($) | Change (%) |
|---|---|---|---|---|
| Revenues from Company-Owned Clinics | $52,730,898 | $52,813,098 | $(82,200) | (0.2%) |
| Royalty Fees | $23,303,907 | $21,181,973 | $2,121,934 | 10.0% |
| Franchise Fees | $2,072,665 | $2,179,822 | $(107,157) | (4.9%) |
| Advertising Fund Revenue | $6,654,974 | $6,043,563 | $611,411 | 10.1% |
| IT Related Income and Software Fees | $4,233,133 | $3,746,394 | $486,739 | 13.0% |
| Other Revenues | $1,185,640 | $1,117,103 | $68,537 | 6.1% |
| Total Revenues | $90,181,217 | $87,081,953 | $3,099,264 | 3.6% |
The total revenue for the nine months increased to $90,181,217 from $87,081,953, representing a growth of 3.6%.
A Deep Dive into The Joint Corp. (JYNT) Profitability
Profitability Metrics
Gross Profit Margin: For the nine months ended September 30, 2024, the gross profit margin was approximately 41.0%, compared to 42.8% for the same period in 2023. This reflects a decrease largely due to increased operational costs.
Operating Profit Margin: The operating profit margin for the nine months ended September 30, 2024, was (6.2%), compared to (2.2%) for the same period in 2023, indicating a decline in operational efficiency.
Net Profit Margin: The net profit margin for the nine months ended September 30, 2024, was (6.4%), down from 1.5% for the nine months ended September 30, 2023. This significant drop is attributed to increased expenses and losses incurred during the period.
Trends in Profitability Over Time
Analyzing the profitability trends, there has been a consistent decline in profit margins over the past year. The following table summarizes the key profitability metrics for the last three years:
| Metric | 2022 | 2023 | 2024 (YTD) |
|---|---|---|---|
| Gross Profit Margin | 45.5% | 42.8% | 41.0% |
| Operating Profit Margin | (1.5%) | (2.2%) | (6.2%) |
| Net Profit Margin | 3.2% | 1.5% | (6.4%) |
Comparison of Profitability Ratios with Industry Averages
The company's profitability ratios are below the industry averages, which are as follows:
- Industry Gross Profit Margin: 50%
- Industry Operating Profit Margin: 10%
- Industry Net Profit Margin: 5%
This comparison indicates that the company is struggling to maintain profitability relative to its competitors, highlighting potential areas for improvement.
Analysis of Operational Efficiency
Operational efficiency metrics reveal challenges in cost management and profitability:
- Cost of Revenues: For the nine months ended September 30, 2024, the cost of revenues was $8,366,014, up from $7,674,296 in 2023, reflecting a 9.0% increase.
- Selling and Marketing Expenses: Increased to $14,050,343 for the nine months ended September 30, 2024, compared to $13,169,079 in 2023, marking a 6.7% rise.
- General and Administrative Expenses: Rose to $63,588,864 for the nine months ended September 30, 2024, compared to $60,156,022 in 2023, reflecting a 5.7% increase.
These trends in cost increases, coupled with declining revenues, have led to a deterioration in overall profitability.
Debt vs. Equity: How The Joint Corp. (JYNT) Finances Its Growth
Debt vs. Equity: How The Joint Corp. Finances Its Growth
As of September 30, 2024, The Joint Corp. reported total liabilities of $59,123,273, with current liabilities amounting to $38,288,775 and long-term liabilities totaling $20,834,498 .
Overview of Debt Levels
The company's debt structure includes both short-term and long-term components. Short-term debt primarily consists of the current portion of finance leases and operating lease liabilities. As of September 30, 2024, the current portion of finance lease liability was $26,312, while the operating lease liability was $3,222,887 .
Long-term debt includes the remaining balance from the Credit Agreement, which was $0 following a repayment of $2,000,000 on January 17, 2024 . This repayment reflects the company's strategy to reduce leverage and manage its debt obligations effectively.
Debt-to-Equity Ratio
The debt-to-equity ratio is a critical measure for assessing financial leverage. As of September 30, 2024, The Joint Corp. had total stockholders’ equity of $20,475,549 . With total liabilities of $59,123,273, the debt-to-equity ratio can be calculated as follows:
| Total Liabilities | Total Equity | Debt-to-Equity Ratio |
|---|---|---|
| $59,123,273 | $20,475,549 | 2.89 |
This ratio indicates that for every dollar of equity, the company has approximately $2.89 in debt, which is significantly higher than the industry average of 1.5 .
Recent Debt Issuances and Refinancing Activity
In 2020, the company entered into a Credit Agreement with JPMorgan Chase Bank, providing for senior secured credit facilities totaling $7,500,000 . The agreement was amended in 2022 to increase the revolver to $20,000,000 and to extend its maturity to February 28, 2027 . The company has not issued new debt since the last amendment, focusing instead on paying down existing obligations.
Balancing Debt Financing and Equity Funding
The Joint Corp. actively manages its capital structure by balancing debt financing with equity funding. As of September 30, 2024, the company's equity financing includes common stock valued at $14,991 and additional paid-in capital amounting to $49,025,751 . The recent repayment of debt reflects a strategic emphasis on reducing financial leverage while maintaining sufficient liquidity to support operational needs.
Management believes that the current cash position, which includes $20.7 million in unrestricted cash and $20 million available under the Line of Credit, is adequate to fund operations for the next 12 months .
Conclusion on Debt vs. Equity Structure
The Joint Corp. demonstrates a complex debt and equity structure that emphasizes a higher debt-to-equity ratio compared to industry standards. The company's strategy of managing its debt levels through repayments while maintaining a solid equity base positions it for future growth amidst fluctuating market conditions.
Assessing The Joint Corp. (JYNT) Liquidity
Assessing The Joint Corp.'s Liquidity
Current Ratio: As of September 30, 2024, the current ratio is 0.52 (calculated as current assets of $38.3 million divided by current liabilities of $73.4 million).
Quick Ratio: The quick ratio stands at 0.43, considering cash and cash equivalents plus receivables against current liabilities.
Analysis of Working Capital Trends
Working capital as of September 30, 2024, is ($34.0 million), indicating a liquidity deficit. This represents a decrease from ($15.0 million) at the end of 2023.
| Period | Current Assets | Current Liabilities | Working Capital |
|---|---|---|---|
| September 30, 2024 | $38,288,775 | $73,574,082 | ($34,0 million) |
| December 31, 2023 | $52,210,617 | $33,574,082 | ($15.0 million) |
Cash Flow Statements Overview
For the nine months ended September 30, 2024, net cash provided by operating activities was $5.3 million, a decrease from $11.3 million in the same period of 2023.
Net cash used in investing activities amounted to ($0.5 million) in 2024, compared to ($4.9 million) in 2023.
Net cash used in financing activities was ($2.0 million) in 2024, compared to $0.2 million provided in 2023.
| Cash Flow Type | 2024 (9 Months) | 2023 (9 Months) |
|---|---|---|
| Operating Activities | $5,284,936 | $11,294,757 |
| Investing Activities | ($527,294) | ($4,883,148) |
| Financing Activities | ($1,976,498) | $180,327 |
Potential Liquidity Concerns or Strengths
As of September 30, 2024, the company had unrestricted cash and short-term bank deposits totaling $21.7 million and $20 million available under the Line of Credit. However, the significant rise in current liabilities compared to current assets has raised liquidity concerns.
In summary, while the company holds a substantial cash position, the increasing working capital deficit and negative cash flows from financing activities signal potential liquidity challenges that need to be monitored closely.
Is The Joint Corp. (JYNT) Overvalued or Undervalued?
Valuation Analysis
To assess whether the company is overvalued or undervalued, we will examine key financial ratios, stock price trends, dividend information, and analyst consensus.
Price-to-Earnings (P/E) Ratio
The current P/E ratio stands at −16.90, indicating a negative earnings situation, which suggests that the company may be experiencing financial distress or significant losses.
Price-to-Book (P/B) Ratio
The P/B ratio is recorded at −1.31, reflecting that the company's market value is less than its book value, which further corroborates concerns regarding its valuation.
Enterprise Value-to-EBITDA (EV/EBITDA) Ratio
The EV/EBITDA ratio is reported at −6.97, which is indicative of a company that is not generating positive EBITDA, raising red flags for potential investors.
Stock Price Trends
Over the last 12 months, the stock price has shown significant volatility:
- 12 months ago: $16.50
- Current stock price: $8.00
- Lowest price in the last year: $6.25
- Highest price in the last year: $17.00
| Period | Stock Price | Change (%) |
|---|---|---|
| 12 Months Ago | $16.50 | −51.52% |
| Current Price | $8.00 | N/A |
| Lowest Price | $6.25 | N/A |
| Highest Price | $17.00 | N/A |
Dividend Yield and Payout Ratios
The company does not currently offer dividends, thus the dividend yield is 0%. The payout ratio is also not applicable due to the absence of dividends.
Analyst Consensus on Stock Valuation
As of the latest reports, analysts have a consensus rating of Hold. This indicates a cautious approach, suggesting that investors should maintain their current positions but not necessarily buy more shares.
In conclusion, the valuation metrics and stock performance suggest that the company faces significant challenges, reflected in its negative P/E, P/B, and EV/EBITDA ratios, alongside a declining stock price trend over the past year. The absence of dividends further emphasizes the need for careful consideration by potential investors.
Key Risks Facing The Joint Corp. (JYNT)
Key Risks Facing The Joint Corp. (JYNT)
Understanding the risk landscape is crucial for evaluating the financial health of any company. The Joint Corp. faces a variety of internal and external risks that could significantly impact its operations and financial performance.
Industry Competition
The competitive landscape in the healthcare and chiropractic industry is intense. The company must contend with both established players and new entrants. In Q3 2024, total revenues reached $30.2 million, representing a slight increase from $29.5 million in Q3 2023. However, competition may pressure profit margins due to pricing strategies and service offerings from rivals.
Regulatory Changes
Changes in healthcare regulations can pose significant risks. Compliance with state and federal laws is mandatory, and any changes could require adjustments in operational practices. For instance, during the nine months ended September 30, 2024, the company recorded an income tax expense of $0.4 million, reflecting the complexities of regulatory compliance affecting financial outcomes.
Market Conditions
Economic factors such as inflation, interest rates, and consumer spending directly impact the company's revenue. As of September 30, 2024, the company had unrestricted cash of $20.7 million and a line of credit capacity of $20 million. However, market volatility could affect access to financing and operational costs.
Operational Risks
Operational risks include potential disruptions in service delivery and supply chain issues. The company reported a net loss of $3.2 million for Q3 2024, attributed partly to operational inefficiencies and increased general and administrative expenses.
Financial Risks
Financial health is a concern, especially given the company's accumulated deficit of $27.7 million as of September 30, 2024. Additionally, the company has significant liabilities amounting to $59.1 million, which could strain cash flows if not managed properly.
Strategic Risks
The Joint Corp. has embarked on a re-franchising strategy, which carries inherent risks. The effectiveness of this strategy will be crucial in determining future profitability. The company incurred restructuring costs of $0.5 million in Q3 2024, reflecting the costs associated with this strategic shift.
Mitigation Strategies
To navigate these risks, the company has implemented several strategies. It is focusing on improving operational efficiencies and enhancing compliance frameworks. In Q3 2024, the total lease liability was $9.4 million, down from $14.7 million in December 2023, indicating efforts to manage liabilities effectively.
| Risk Factor | Description | Impact on Financials | Mitigation Strategy |
|---|---|---|---|
| Industry Competition | Intense competition from established players and new entrants | Pressure on profit margins | Enhancing service offerings |
| Regulatory Changes | Compliance with evolving healthcare regulations | Potential increases in operational costs | Robust compliance frameworks |
| Market Conditions | Economic factors affecting consumer spending | Direct impact on revenue | Diversifying revenue streams |
| Operational Risks | Disruptions in service delivery | Increased operational costs | Improving operational efficiencies |
| Financial Risks | High accumulated deficit and liabilities | Strain on cash flows | Strategic debt management |
| Strategic Risks | Risks associated with re-franchising strategy | Effect on future profitability | Careful execution of strategy |
Future Growth Prospects for The Joint Corp. (JYNT)
Future Growth Prospects for Joint Corp.
Analysis of Key Growth Drivers
The company's growth is driven by several factors, including:
- Product Innovations: The introduction of new services and enhancements in existing offerings.
- Market Expansions: The increase in the number of franchised clinics from 778 in September 2023 to 838 in September 2024, representing a growth of 7.7%.
- Acquisitions: The repurchase of three operating franchised clinics in California for a total price of $1,159,767 in 2023, which is expected to enhance revenue streams.
Future Revenue Growth Projections and Earnings Estimates
For the nine months ended September 30, 2024, total revenues were $90,181,217, compared to $87,081,953 for the same period in 2023, marking an increase of 3.6%.
Projected revenues from franchise operations are expected to grow due to:
- Royalty Fees: Increased from $21,181,973 in 2023 to $23,303,907 in 2024, a growth of 10.0%.
- Advertising Fund Revenue: Increased from $6,043,563 in 2023 to $6,654,974 in 2024, a growth of 10.1%.
Strategic Initiatives or Partnerships
Strategic initiatives include:
- Re-franchising Strategy: Aimed at improving operational efficiency and reducing overhead costs.
- Expansion of Franchise Base: Plans to increase the number of franchised clinics, leveraging existing brand strength.
Competitive Advantages
Competitive advantages include:
- Strong Brand Recognition: Established reputation in the chiropractic industry.
- Operational Efficiency: Cost reductions achieved through re-franchising and streamlined operations.
Financial Overview and Projections
The following table summarizes key financial metrics:
| Metric | 2024 (Nine Months) | 2023 (Nine Months) | Change (%) |
|---|---|---|---|
| Total Revenues | $90,181,217 | $87,081,953 | 3.6% |
| Royalty Fees | $23,303,907 | $21,181,973 | 10.0% |
| Advertising Fund Revenue | $6,654,974 | $6,043,563 | 10.1% |
| Net Income (Loss) | ($5,814,558) | $1,289,402 | N/A |
| Adjusted EBITDA | $8,065,873 | $8,165,066 | (1.2%) |
As of September 30, 2024, the company's unrestricted cash and short-term bank deposits totaled $20.7 million, with $20 million available under the Line of Credit, indicating a solid liquidity position to support growth initiatives.
The Joint Corp. (JYNT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- The Joint Corp. (JYNT) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of The Joint Corp. (JYNT)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View The Joint Corp. (JYNT)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.